Download PDF
Thromb Haemost 1994; 71(01): 160-161
DOI: 10.1055/s-0038-1642405
Letter to the Editor
Schattauer GmbH Stuttgart

Prevalence of Elevated Histidine-Rich Glycoprotein in Patients with Thrombophilia - a Study of 695 Patients

S Ehrenforth
J. W. Goethe University Hospital, Frankfurt, Germany
,
E Aygören-Pürsün
J. W. Goethe University Hospital, Frankfurt, Germany
,
V Hach-Wunderle
J. W. Goethe University Hospital, Frankfurt, Germany
,
I Scharrer
J. W. Goethe University Hospital, Frankfurt, Germany
› Author Affiliations
Further Information

Publication History

Received: 02 September 1993

Accepted without change 28 September 1993

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Engesser L, Kluft C, Briet E, Brommer EJ P. Familial elevation of plasma histidine-rich glycoprotein in a family with thrombophilia. Br J Haematol 1987; 67: 355-8
    CrossrefPubMedGoogle Scholar
  • 2 Castaman G, Ruggeri M, Burei F, Rodeghiero F. High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families. Thromb Res 1993; 69: 297-305
    CrossrefPubMedGoogle Scholar
  • 3 Falkon L, Gari M, Montserrat I, Muniz E, Borell M, Fonteuberta J. Familial elevation of plasma histidine-rich glycoprotein: a case associated with recurrent venous thrombosis and high PAI-1 levels. Thromb Res 1992; 66: 265-70
    CrossrefPubMedGoogle Scholar
  • 4 Schved JF, Gris JC, Martinez P, Sarlat C, Sanchez N, Arnaud A. Familial thrombophilia associated with familial elevation of plasma histidine-rich glycoprotein and Type I plasminogen activator inhibitor. Thromb Haemostas 1991; 65 (06) 1044
    PubMedGoogle Scholar
  • 5 Angeles-Cano E, Gris JC, Loyau S, Schved JF. Familial association of high leves of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. J Lab Clin Med 1993; 121 (05) 646-53
    PubMedGoogle Scholar
  • 6 Shigekiyo T, Oshima T, Oka H, Tomonari A, Azuma H, Saito S. Congenital Histidine-Rich Glycoprotein Deficiency. Thromb Haemostas 1993; 70 (02) 263-5
    PubMedGoogle Scholar
  • 7 Heimburger N, Haupt H, Kranz T, Baudner S. Humanserumproteine mit hoher Affinität zu Carboxymethylcellulose, II. Hoppe-Seyler's Z Physiolo Chem 1972; 353: 1133-40
    PubMedGoogle Scholar
  • 8 Leung LK L, Harpel PC, Nachmann RL, Rabel lino EM. Histidine-rich glycoproteins is present in human platelets and is released following thrombin stimulation. Blood 1983; 62: 1016-21
    PubMedGoogle Scholar
  • 9 Koide T, Foster D, Yoshitake S, Davie EW. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotid sequence of its cDNA. Biochemistry 1986; 25: 2220-5
    CrossrefPubMedGoogle Scholar
  • 10 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of human plasma protein with high affinity for lysine binding sites in plasminogen. Journal of Biological Chemistry 1980; 225: 10214-22
    PubMedGoogle Scholar
  • 11 Leung LK L, Harpel PC, Nachmann RL. Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin invest 1984; 73: 5-12
    CrossrefPubMedGoogle Scholar
  • 12 Leung LL K. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 1986; 77: 1305-11
    CrossrefPubMedGoogle Scholar
  • 13 Silvcrstein RL, Leung LL K, Harpel PC, Nachmann RL. Platelet thrombospondin forms a trimolccular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest 1985; 75: 2065-73
    CrossrefPubMedGoogle Scholar
  • 14 Lijnen HR, Hoylaerts M, Collen D. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. J Biol Chem 1983; 258: 3803-8
    PubMedGoogle Scholar
  • 15 Tollefsen DM, Pestka CA. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4. J Clin Invest 1985; 75: 496-501
    CrossrefPubMedGoogle Scholar
  • 16 Niwa M, Yamagishi R, Kondo S, Sakuragawa N, Koide T. Histidine-rich glycoprotein inhibits the antithrombin activity of heparin cofactor II in the presence of heparin or dermatan sulfate. Thromb Res 1985; 37: 237-40
    CrossrefPubMedGoogle Scholar
  • 17 Kazama Y, Koide T. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein. Thromb Haemostas 1992; 67 (01) 50-5
    PubMedGoogle Scholar
  • 18 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Annal Biochem 1966; 15: 45-52
    CrossrefPubMedGoogle Scholar
  • 19 Solberg HE. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 645-56
    PubMedGoogle Scholar
  • 20 Engesser L, Kluft C, Juhan-Vague I, Briet E, Brommer EJ P. Plasma histidine-rich glycoprotein and thrombophilia. Fibrinolysis 1988; 2 (suppl 2) 43-6
    PubMedGoogle Scholar